What real Veozah reviews say: side effects, fading relief, and who it actually helped

What do real Veozah reviews say overall?

The two biggest public review sites don't fully agree, and that gap is useful. On Drugs.com, Veozah averages 7.4 out of 10 across 64 reviews. A little over half rate it positively. Fewer than one in ten rate it negatively. The rest sit in a mixed or lukewarm middle.

WebMD's pool is smaller and reads warmer. Its 43 reviews average 4 out of 5 stars, and about 88% of reviewers report a positive effect. Part of the gap is sample size: a few very happy or very unhappy people can swing a small group. Part may be who chooses to post on each site. Neither site says how it screens reviews.

Put together, the picture is honest but not simple. Most women who try Veozah are glad they did. About one in ten had a bad experience on either site. On Drugs.com, roughly a third more call it only so-so. That is a better expectation to start with than either the ads or a trial summary.

Which side effects do real users report most, and how does that compare with the label?

Veozah's FDA label lists the side effects from its 52-week safety trial. Each was reported by at least 2% of women on Veozah, and more often than on placebo, a dummy pill:

• Belly pain: 4.3% on Veozah, 2.1% on placebo
• Diarrhea: 3.9% on Veozah, 2.6% on placebo
• Trouble sleeping: 3.9% on Veozah, 1.8% on placebo
• Back pain: 3.0% on Veozah, 2.1% on placebo
• More hot flashes for a while: 2.5% on Veozah, 1.6% on placebo
• Raised liver enzymes: 2.3% on Veozah, 0.8% on placebo. These are a blood-test sign of liver stress, and the reason for the boxed warning, the FDA's strongest safety label.

For the full label list, see Veozah side effects.

Reviewers name some of the same problems, but in a different order. On Drugs.com, nausea, headache, insomnia, dizziness and back or tailbone pain come up again and again. WebMD reviewers add joint pain, sinus irritation, irritability and unusually vivid dreams. None of those lead the label's list.

Insomnia and back pain show up in both places, so they are no surprise. Nausea, dizziness and odd dreams loom larger in reviews than on the label. A trial counts how often things happen. A woman describing her own week picks up things a checklist never asks about.

Does Veozah stop working over time? The 'relief faded at month 3 to 6' pattern

This is the theme worth knowing before you start. A recurring group of reviewers describe the same arc. Relief comes fast, sometimes dramatically, in the first weeks. Then hot flashes and night sweats creep back somewhere between month three and month six. For some women, they return close to where they started.

• Strong relief for four to five months, then hot flashes returning until she stopped the drug
• Night sweats and dizziness getting worse around three and a half months, after a good start
• Symptoms controlled for about six months, then coming back slowly, then faster

Be careful about what this proves. In the SKYLIGHT trials, the benefit held on average through 52 weeks. So fading relief is a real pattern in some reviews, not the drug's typical course. The reviews don't settle why it happens. The body may adapt, or menopause may simply move on.

Who says Veozah worked well, and what do they have in common?

The happiest reviewers share a few traits. Many are breast cancer survivors, or have another reason they can't use hormone therapy. For them, Veozah isn't competing with hormones. It's competing with older non-hormonal drugs that didn't do enough, or with nothing at all.

• Tried an antidepressant first: they had used an SSRI or SNRI, such as venlafaxine, for hot flashes and found Veozah stronger. These antidepressant families can ease hot flashes at low doses.
• Felt relief fast: within days to about a week. That fits the trials, where hot flashes began to ease in the first week.
• Had one clear target: hot flashes and night sweats, the only symptoms Veozah is approved to treat.
• Had coverage in place: insurance plus the Astellas savings card, at about $30 a month, so cost didn't force an early stop.

That last point matters more than it seems. A woman paying close to the full cash price is more likely to quit if the first weeks feel flat. At about $30 a month, there is room to give the drug a fair trial.

Who says it didn't work, or stopped taking it?

Not every bad review is about a side effect. Some women saw no real change after a fair trial. One describes three months of ongoing hot flashes, with insomnia, stomach pain and diarrhea added on top.

• No real drop in hot flashes: even after two to three months on the drug
• Relief that faded: the pattern above, which led them to stop
• Cost: the price became too much before insurance or the savings card kicked in
• Other symptoms mattered too: sleep, mood, vaginal dryness or bone health. Hormone therapy covered more of them at once.

That last reason is a scope mismatch more than a failure. Veozah is approved only for hot flashes and night sweats. A woman whose main complaints go wider will find that narrow lane frustrating, however well it does its one job.

The complaints that aren't about the medicine

A steady thread on both sites has nothing to do with how the drug works. Reviewers mention high cash prices, insurance denials and prior authorization. That is an approval the plan must give before it pays. Some plans also want proof that hormone therapy failed or isn't safe for you. For several women, this paperwork nearly stopped them before they started.

One WebMD reviewer simply wished it were covered. Another went from over $500 a month to about $40 once the maker's savings program applied.

What women say on Reddit and forums, and how to weigh a post against a rating site

We searched for a large, organized Reddit thread on Veozah and didn't find one to point to. What exists is scattered chatter on menopause forums. It echoes the same themes: fast relief for many, fading relief for some, and frequent cost complaints.

The two formats measure different things. A rating site averages dozens of people into one number. That's a quick gut check, but it flattens each story. A forum post is the opposite: rich detail from one person. Forums also lean toward posts that are very good or very bad, not just fine.

So weigh the detail, not just the mood. A dated post with symptoms, timeline and dose is worth far more than a one-line 'stay away' with no context.

Do any reviewers mention liver problems?

Barely. Among the reviews we read, one WebMD reviewer asked about possible effects on liver enzymes, the AST and ALT values on a blood test. That reads as a worry prompted by the boxed warning, not a report of confirmed liver injury. We found no cluster of reviewers describing actual liver damage.

That fits the record. The FDA added the boxed warning in December 2024, after a report of serious liver injury in a woman about 40 days into treatment. The required liver blood tests exist to catch a rare problem early. For the full regulatory record and the testing schedule, see is Veozah legit?

How do reviews of Veozah compare with reviews of hormone therapy?

The efficacy numbers live in the full Veozah vs. HRT comparison. The tone of the reviews is still worth a word. Hormone therapy reviews have their own complaints: breakthrough bleeding, breast tenderness, and trial and error before finding the right dose or form.

Veozah's reviewers often frame it as the option for women who can't or won't take hormones. So some reviews that sound like settling aren't Veozah losing to hormones. They come from women for whom hormones were never on the table.

So, based on real user experience, is Veozah worth trying?

For a woman who can't or would rather not use hormone therapy, the reviews support a real trial. Most people report meaningful relief, often within the first couple of weeks. The common side effects are the ordinary kind you'd weigh for any new prescription.

Go in ready for two things. First, your price depends heavily on insurance and the savings card. Second, strong early relief may soften around month three to six, so raise that with your prescriber at the start. For the trial-backed timeline, see how long Veozah takes to work.

Veozah is also no longer the only non-hormonal pill of its kind. Lynkuet, from Bayer, was approved in October 2025. It blocks the same brain signal, plus a second one. Veozah alternatives and their prices compares it with every other option.